As of today (2026-06-24), the Forward Annual Dividend Yield of Eurofins Scientific SE is 1.11%.
As of today (2026-06-24), the Trailing Annual Dividend Yield of Eurofins Scientific SE is 1.11%.
ERFSF's Forward Dividend Yield % is ranked worse than 67.74% of 62
companies
in the Medical Diagnostics & Research industry
Industry Median: 1.89
vs ERFSF: 1.11
During the past 12 months, Eurofins Scientific SE's average Dividends Per Share Growth Rate was 20.00% per year.
During the past 3 years, the average Dividends Per Share Growth Rate was -15.70% per year.
During the past 13 years, the highest 3-Year average Dividends Per Share Growth Rate of Eurofins Scientific SE was 100.00% per year. The lowest was -62.40% per year. And the median was 23.90% per year.
The growth rate is calculated with least square regression.
For more information regarding to dividend, please check our Dividend Page.
Eurofins Scientific SE (OTCPK:ERFSF) Forward Dividend Yield % Explanation
Over the long term, the return from dividends has been a significant contributor to the total returns produced by equity securities. Studies by Elroy Dimson, Paul Marsh, and Mike Staunton of Princeton University (2002) found that a market-oriented portfolio, which included reinvested dividends, would have generated nearly 85 times the wealth generated by the same portfolio relying solely on capital gains.
Dividends may also qualify a lower tax rate for investors.
In dividends investing, Payout Ratio and Dividend Growth Rate are the two most important variables for consideration. A lower payout ratio may indicate that the company has more room to increase its dividends.
Eurofins Scientific SE Forward Dividend Yield % Related Terms
ERFSF vs TMO, DHR, IDXX: Forward Dividend Yield % Comparison
For the Diagnostics & Research subindustry, Eurofins Scientific SE's Forward Dividend Yield %, along with its competitors' market caps and Forward Dividend Yield % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Eurofins Scientific SE Forward Dividend Yield % vs Medical Diagnostics & Research Industry
For the Medical Diagnostics & Research industry and Healthcare sector, Eurofins Scientific SE's Forward Dividend Yield % distribution charts can be found below:
* The bar in red indicates where Eurofins Scientific SE's Forward Dividend Yield % falls into.
Eurofins Scientific SE Forward Dividend Yield % Calculation
Dividend Yield measures how much a company pays out in dividends each year relative to its share price.
Eurofins Scientific SE Recent Full-Year* Dividend History
Amount
Ex-date
Record Date
Pay Date
Type
Frequency
Forex Rate
EUR 0.720000
2026-04-28
2026-04-29
2026-04-30
Cash Dividend
annually
EUR:USD 1.156069
* GuruFocus has an internal rule that if the most recent dividend payment frequency is at least 4 times a year, then the full year will be calculated according to the frequency of payment or the one-year time frame, whichever is stricter.
* GuruFocus converts dividend currency to local traded share price currency in order to calculate dividend yield. Please refer to the last column "Forex Rate" in the above table.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
What does a Forward Dividend Yield % of 1.11% mean?
Eurofins Scientific SE (ERFSF) has a Forward Dividend Yield % of 1.11% as of Jun. 24, 2026. Forward dividend yield is the ratio of company's expected dividends to the share price. View historical data on Eurofins Scientific SE and its competitors. According to the industry distribution chart, Eurofins Scientific SE ranks #42 out of 62 companies in the Medical Diagnostics & Research industry, placing it in the top 67.7%.
Is Eurofins Scientific SE's Forward Dividend Yield % too high?
Eurofins Scientific SE's current Forward Dividend Yield % is 1.11%. The Medical Diagnostics & Research industry median Forward Dividend Yield % is 1.89. Eurofins Scientific SE's value of 1.11% is 41.3% below this industry median. Based on the distribution chart, Eurofins Scientific SE ranks #42 out of 62 companies in the Medical Diagnostics & Research industry, which is below the industry midpoint. Overall, Eurofins Scientific SE has a GF Score™ of 81/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Eurofins Scientific SE's Forward Dividend Yield % compare to TMO and DHR?
According to the Medical Diagnostics & Research industry distribution chart, Eurofins Scientific SE ranks #42 out of 62 companies for Forward Dividend Yield %. This places Eurofins Scientific SE in the lower half of its industry. The industry median Forward Dividend Yield % is 1.89. Eurofins Scientific SE's value of 1.11% is 41.3% below this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Forward Dividend Yield % for a Medical Diagnostics & Research company?
The median Forward Dividend Yield % among Medical Diagnostics & Research companies is 1.89, based on 62 companies in the industry. Companies in the top quartile (top 25%) have a Forward Dividend Yield % significantly above this median, while those in the bottom quartile fall well below. However, Forward Dividend Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Eurofins Scientific SE's current Forward Dividend Yield % of 1.11% is 41.3% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Forward Dividend Yield % mean?
A high Forward Dividend Yield % can signal that a stock is expensive relative to its fundamentals. Forward dividend yield is the ratio of company's expected dividends to the share price. View historical data on Eurofins Scientific SE and its competitors. For the Medical Diagnostics & Research industry, the median Forward Dividend Yield % is 1.89 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Eurofins Scientific SE's current Forward Dividend Yield % is 1.11%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Eurofins Scientific SE stock overvalued right now?
Based on GuruFocus' analysis, Eurofins Scientific SE (ERFSF) is currently considered Fairly Valued. The stock's GF Value™ is $76.00, compared to a current price of $76.03 — trading 0% above its estimated fair value. The current Forward Dividend Yield % is 1.11% and 41.3% below the Medical Diagnostics & Research industry median of 1.89. Eurofins Scientific SE's overall GF Score™ is 81/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Forward Dividend Yield % calculated?
Forward Dividend Yield % is calculated from a company's financial statements. For Eurofins Scientific SE (ERFSF), the current Forward Dividend Yield % is 1.11% as of Jun. 24, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Eurofins Scientific SE (ERFSF) Overvalued in 2026?
Based on GuruFocus' analysis, Eurofins Scientific SE stock appears to be overvalued.
The current stock price of $76.03 is trading 0% above its estimated GF Value™ of $76.00.
GuruFocus considers Eurofins Scientific SE to be Fairly Valued.
Key valuation signals for ERFSF:
Forward Dividend Yield %: 1.11%
GF Value™: $76.00 vs. price of $76.03 (0% above fair value)
Industry Position: 41.3% below the Medical Diagnostics & Research median (#42 of 62)
No single metric tells the full story. See the ERFSF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Eurofins, headquartered in Luxembourg, is a decentralized network of life sciences companies that provide various analytical tests and laboratory services. These include tests to evaluate the safety, identity, composition, authenticity, purity, origin, and traceability of various biological substances and products. Eurofins operates over 950 laboratories in 61 countries. Its revenue from Europe, North America, and the rest of the world contributes approximately 50%, 40%, and 10% of total revenue, respectively. Its areas of business activity are food, feed, and environmental testing ("life"), biopharmaceutical services, diagnostic services and products, and consumer and technology products testing, which contribute approximately 40%, 30%, 20%, and 10% respectively.
81GF Score
Get the complete analysis for ERFSF
Forward Dividend Yield % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ERFSF has been successfully added to your 